{
    "organizations": [],
    "uuid": "185d0f51b779af3d4791d756d30d5b673ee20947",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/08/the-associated-press-oncomed-tops-street-4q-forecasts.html",
    "ord_in_thread": 0,
    "title": "OncoMed tops Street 4Q forecasts",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "REDWOOD CITY, Calif. (AP) _ OncoMed Pharmaceuticals Inc. (OMED) on Thursday reported fourth-quarter net income of $9.5 million, after reporting a loss in the same period a year earlier.\nThe Redwood City, California-based company said it had profit of 25 cents per share.\nThe results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.\nThe cancer therapy developer posted revenue of $20.6 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $5.1 million.\nFor the year, the company reported that its loss narrowed to $39.1 million, or $1.04 per share. Revenue was reported as $38.2 million.\nIn the final minutes of trading on Thursday, the company's shares hit $2.89. A year ago, they were trading at $9.14.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on OMED at https://www.zacks.com/ap/OMED",
    "published": "2018-03-08T23:37:00.000+02:00",
    "crawled": "2018-03-09T09:50:57.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "redwood",
        "city",
        "ap",
        "oncomed",
        "pharmaceutical",
        "omed",
        "thursday",
        "reported",
        "net",
        "income",
        "million",
        "reporting",
        "loss",
        "period",
        "year",
        "earlier",
        "redwood",
        "city",
        "company",
        "said",
        "profit",
        "cent",
        "per",
        "share",
        "result",
        "beat",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "five",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "cancer",
        "therapy",
        "developer",
        "posted",
        "revenue",
        "million",
        "period",
        "also",
        "topped",
        "street",
        "forecast",
        "four",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "million",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "final",
        "minute",
        "trading",
        "thursday",
        "company",
        "share",
        "hit",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "omed",
        "http"
    ]
}